| User's Publication |
|
16215
Manami Suzuki-Karasaki, Takashi Ando, Yushi Ochiai, Kenta Kawahara, Miki Suzuki-Karasaki, Hideki Nakayama, Yoshihiro Suzuki-Karasaki
Air Plasma-Activated Medium Evokes a Death-Associated Perinuclear Mitochondrial Clustering
Int J Mol Sci
2022
23(3):1124
PubMed ID: 35163042
|
|
16237
Inoue M, Horiuchi K, Susa M, Taguchi E, Ishizaka T, Rikitake H, Matsuhashi Y, Chiba K.
Trabectedin suppresses osteosarcoma pulmonary metastasis in a mouse tumor xenograft model
J Orthop Res
2022
May 31
PubMed ID: 34057747
|
|
20656
Ogiwara Y, Nakagawa M, Nakatani F, Uemura Y, Zhang R, Kudo-Saito C.
Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma.
Cancer Lett
2022
537:215690
PubMed ID: 35439537
|
|
20032
Lin L, Wang H, Guo W, He E, Huang K, Zhao Q.
Osteosarcoma-derived exosomal miR-501-3p promotes osteoclastogenesis and aggravates bone loss.
Cell Signal
2021
82:109935
PubMed ID: 33529755
|
|
13630
Hennessy M, Wahba A, Felix K, Cabrera M, Segura MG, Kundra V, Ravoori MK, Stewart J, Kleinerman ES, Jensen VB, Gopalakrishnan V, Pena R, Quach P, Kim G, Kivimäe S, Madakamutil L, Overwijk WW, Zalevsky J, Gordon N.
Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma
Int J Cancer
2021
148(8):1928-1937
PubMed ID: 33152115
|
|
14340
Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, Rajasekhar VK, Yoshida A, Kondo H, Hata T, Tazawa H, Dogan Y, Moore MAS, Fujiwara T, Ozaki T, Purdue E, Healey JH.
CSF-1/CSF-1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-Cell Infiltration in the Sarcoma Microenvironment
Mol Cancer Ther
2021
PubMed ID: 34088832
|
|
14344
Araki Y, Aiba H, Yoshida T, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Igarashi K, Nguyen TD, Ishii KA, Nojima T, Takahashi S, Murakami H, Tsuchiya H, Hanayama R.
Osteosarcoma-Derived Small Extracellular Vesicles Enhance Tumor Metastasis and Suppress Osteoclastogenesis by miR-146a-5p
Front Oncol
2021
11:667109.
PubMed ID: 34017686
|
|
15140
Matsusaka K, Fujiwara Y, Pan C, Esumi S, Saito Y, Bi J, Nakamura Y, Mukunoki A, Takeo T, Nakagata N, Yoshii D, Fukuda R, Nagasaki T, Tanaka R, Komori H, Maeda H, Watanabe H, Tamada K, Komohara Y, Maruyama T.
α1-acid glycoprotein enhances the immunosuppressive and protumor functions of tumor-associated macrophages
Cancer Res
2021
canres.3471.2020
PubMed ID: 34210751
|
|
20267
Maruyama K, Okada T, Ueha T, Isohashi K, Ikeda H, Kanai Y, Sasaki K, Gentsu T, Ueshima E, Sofue K, Nogami M, Yamaguchi M, Sugimoto K, Sakai Y, Hatazawa J, Murakami T.
In vivo evaluation of percutaneous carbon dioxide treatment for improving intratumoral hypoxia using 18F-fluoromisonidazole PET-CT.
Oncol Lett
2021
21(3):207
PubMed ID: 33574946
|
|
20272
Ma Y, Yoshida T, Matoba K, Kida K, Shintani R, Piao Y, Jin J, Nishino T, Hanayama R.
Identification of small compounds regulating the secretion of extracellular vesicles via a TIM4-affinity ELISA.
Sci Rep
2021
11(1):13471
PubMed ID: 34188113
|
|
16104
Kinoshita H, Shimozato O, Ishii T, Kamoda H, Hagiwara Y, Tsukanishi T, Ohtori S, Yonemoto T.
The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression
Anticancer Res
2021
41(10):4947-4955
PubMed ID: 34593442
|
|
16109
Kinoshita H, Shimozato O, Ishii T, Kamoda H, Hagiwara Y, Ohtori S, Yonemoto T.
The Thioredoxin-1 Inhibitor, PX-12, Suppresses Local Osteosarcoma Progression
Anticancer Res
2021
41(12):6013-6021
PubMed ID: 34848455
|
|
16389
Ideta H, Yoshida K, Okamoto M, Sasaki J, Kito M, Aoki K, Yoshimura Y, Suzuki S, Tanaka A, Takazawa A, Haniu H, Uemura T, Takizawa T, Sobajima A, Kamanaka T, Takahashi J, Kato H, Saito N.
Antitumor Effect of Sclerostin against Osteosarcoma
Cancers (Basel)
2021
13(23):6015
PubMed ID: 34885123
|
|
11888
Yoshida K, Okamoto M, Sasaki J, Kuroda C, Ishida H, Ueda K, Ideta H, Kamanaka T, Sobajima A, Takizawa T, Tanaka M, Aoki K, Uemura T, Kato H, Haniu H, Saito N.
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
BMC Cancer
2020
20(1):25.
PubMed ID: 31914969
|
|
11888
Yoshida K, Okamoto M, Sasaki J, Kuroda C, Ishida H, Ueda K, Ideta H, Kamanaka T, Sobajima A, Takizawa T, Tanaka M, Aoki K, Uemura T, Kato H, Haniu H, Saito N.
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
BMC Cancer
2020
20(1):25.
PubMed ID: 31914969
|
|
12049
Yahiro K, Matsumoto Y, Yamada H, Endo M, Setsu N, Fujiwara T, Nakagawa M, Kimura A, Shimada E, Okada S, Oda Y, Nakashima Y.
Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes.
Cancer Immunol. Immunother.
2020
PubMed ID: 32047957
|
|
13305
Wang X, Xue J, Ma B, Wu J, Chang J, Gelinsky M, Wu C.
Black Bioceramics: Combining Regeneration with Therapy.
Adv Mater
2020
PubMed ID: 33094493
|
|
13306
Ando T, Ichikawa J, Fujimaki T, Taniguchi N, Takayama Y, Haro H.
Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis.
Cancers (Basel)
2020
PubMed ID: 33114161
|
|
13310
Sakuda T, Kubo T, Johan MP, Furuta T, Sakaguchi T, Adachi N.
Development of an Oncolytic Recombinant Vesicular Stomatitis Virus Encoding a Tumor-suppressor MicroRNA.
Anticancer Res
2020
PubMed ID: 33109569
|
|
13527
Takashi Ando, Manami Suzuki-Karasaki, Miki Suzuki-Karasaki, Jiro Ichikawa, Toyoko Ochiai, Yukihiro Yoshida, Hirotaka Haro, Yoshihiro Suzuki-Karasaki
Synergistic anticancer effect of plasma-activated infusion and salinomycin by targeting autophagy and mitochondrial morphology
bioRxiv
2020
October 15
|
|
13532
Pan C, Fujiwara Y, Horlad H, Shiraishi D, Iriki T, Tsuboki J, Ikeda T, Komohara Y.
Flavonoid Compounds Contained in Epimedii Herba Inhibit Tumor Progression by Suppressing STAT3 Activation in the Tumor Microenvironment
Front Pharmacol
2020
11:262
PubMed ID: 32256354
|
|
14872
Ma L, Sakamoto Y, Kanai A, Otsuka H, Takahashi A, Kakimi K, Imai T, Shimokawa T.
Characterization of a Novel Murine Colon Carcinoma Subline with High-Metastatic Activity Established by In Vivo Selection Method
J Mol Sci
2020
21(8):2829
PubMed ID: 32325684
|
|
15141
Takenaka W, Takahashi Y, Tamari K, Minami K, Katsuki S, Seo Y, Isohashi F, Koizumi M, Ogawa K.
Radiation Dose Escalation is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma
Cancers (Basel)
2020
12(6):1546
PubMed ID: 32545427
|
|
12504
Takahashi Y, Yasui T, Minami K, Tamari K, Hayashi K, Otani K, Seo Y, Isohashi F, Koizumi M, Ogawa K.
Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma
Oncotarget
2019
10(6):633-646
PubMed ID: 30774761
|
|
12505
Sakuda T, Kubo T, Johan MP, Furuta T, Sakaguchi T, Nakanishi M, Ochi M, Adachi N.
Novel Near-Infrared Fluorescence-Guided Surgery With Vesicular Stomatitis Virus for Complete Surgical Resection of Osteosarcomas in Mice
J Orthop Res
2019
37(5):1192-1201
PubMed ID: 30839125
|
|
11337
Takahashi A, Wakihata S, Ma L, Adachi T, Hirose H, Yoshida Y, Ohira Y.
Temporary Loading Prevents Cancer Progression and Immune Organ Atrophy Induced by Hind-Limb Unloading in Mice.
Int J Mol Sci
2018
PubMed ID: 30544854
|
|
4277
Shimizu T, Fuchimoto Y, Okita H, Fukuda K, Kitagawa Y, Ueno S, Kuroda T.
A curative treatment strategy using tumor debulking surgery combined with immune checkpoint inhibitors for advanced pediatric solid tumors: An in vivo study using a murine model of osteosarcoma.
J. Pediatr. Surg.
2018
PubMed ID: 30266483
|
|
4278
Johan MP, Kubo T, Furuta T, Sakuda T, Sakaguchi T, Nakanishi M, Ochi M, Adachi N.
Metastatic tumor cells detection and anti-metastatic potential with vesicular stomatitis virus in immunocompetent murine model of osteosarcoma.
J. Orthop. Res.
2018
PubMed ID: 29637599
|
|
9465
Tomohiko Tokunaga, Takashi Ando, Miki Suzuki-Karasaki, Tomohisa Ito, Asuka Onoe-Takahashi, Toyoko Ochiai, Masayoshi Soma , Yoshihiro Suzuki-Karasaki
Plasma-stimulated Medium Kills TRAIL-resistant Human Malignant Cells by Promoting Caspase-Independent Cell Death via Membrane Potential and Calcium Dynamics Modulation
Int J Oncol
2018
52(3):697-708
PubMed ID: 29393427
|
|
14821
Shiraishi D, Fujiwara Y, Horlad H, Saito Y, Iriki T, Tsuboki J, Cheng P, Nakagata N, Mizuta H, Bekki H, Nakashima Y, Oda Y, Takeya M, Komohara Y.
CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma
Cancer Res
2018
78(12):3255-3266
PubMed ID: 29610117
|
|
10239
Kidani T, Yasuda R, Miyawaki J, Oshima Y, Miura H, Masuno H.
Bisphenol A Inhibits Cell Proliferation and Reduces the Motile Potential of Murine LM8 Osteosarcoma Cells.
Anticancer Res.
2017
37:1711-1722
PubMed ID: 28373433
|
|
10496
Shimizu T, Fuchimoto Y, Fukuda K, Okita H, Kitagawa Y, Kuroda T.
The effect of immune checkpoint inhibitors on lung metastases of osteosarcoma.
J. Pediatr. Surg.
2017
52:2047-2050
PubMed ID: 28954696
|
|
14705
Tsuda Y, Tanikawa C, Miyamoto T, Hirata M, Yodsurang V, Zhang YZ, Imoto S, Yamaguchi R, Miyano S, Takayanagi H, Kawano H, Nakagawa H, Tanaka S, Matsuda K.
Identification of a p53 target, CD137L, that mediates growth suppression and immune response of osteosarcoma cells
Sci Rep
2017
7(1):10739
PubMed ID: 28878391
|
|
14753
Takahashi Y, Yasui T, Minami K, Tamari K, Otani K, Seo Y, Isohashi F, Koizumi M, Ogawa K.
Radiation Enhances the Efficacy of Antitumor Immunotherapy with an Immunocomplex of Interleukin-2 and Its Monoclonal Antibody
Anticancer Res
2017
37(12):6799-6806
PubMed ID: 29187458
|
|
9693
Xing Y, Tian Y, Kurosawa T, Matsui S, Touma M, Yanai T, Wu Q, Sugimoto K.
CCL11-induced eosinophils inhibit the formation of blood vessels and cause tumor necrosis.
Genes Cells
2016
21:624-38
PubMed ID: 27169545
|
|
9750
Fujiwara Y, Horlad H, Shiraishi D, Tsuboki J, Kudo R, Ikeda T, Nohara T, Takeya M, Komohara Y.
Onionin A, a sulfur-containing compound isolated from onions, impairs tumor development and lung metastasis by inhibiting the protumoral and immunosuppressive functions of myeloid cells.
Mol Nutr Food Res
2016
60:2467-2480
PubMed ID: 27393711
|
|
9832
Yang D, Okamura H, Morimoto H, Teramachi J, Haneji T.
Protein phosphatase 2A Cα regulates proliferation, migration, and metastasis of osteosarcoma cells.
Lab. Invest.
2016
96:1050-62
PubMed ID: 27617401
|
|
10853
Kazuyuki Itoh
Basic Research for Osteosarcoma Lung Metastasis (LM8)
Osteosarcoma
2016
19-29
|
|
12675
Dovedi SJ, Adlard AL, Ota Y, Murata M, Sugaru E, Koga-Yamakawa E, Eguchi K, Hirose Y, Yamamoto S, Umehara H, Honeychurch J, Cheadle EJ, Hughes G, Jewsbury PJ, Wilkinson RW, Stratford IJ, Illidge TM.
Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy
Oncotarget
2016
7(13):17035-46
PubMed ID: 26959743
|
|
12971
Kawano M, Tanaka K, Itonaga I, Iwasaki T, Miyazaki M, Ikeda S, Tsumura H.
Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma
Oncol Lett
2016
11(3):2169-2175
PubMed ID: 26998143
|
|
7121
Kato S, Mori S, Kodama T.
A Novel Treatment Method for Lymph Node Metastasis Using a Lymphatic Drug Delivery System with Nano/Microbubbles and Ultrasound.
J Cancer
2015
6:1282-94
PubMed ID: 26640589
|
|
7258
Kawano M, Tanaka K, Itonaga I, Iwasaki T, Miyazaki M, Ikeda S, Tsumura H.
Dendritic cells combined with anti-GITR antibody produce antitumor effects in osteosarcoma.
Oncol. Rep.
2015
34:1995-2001
PubMed ID: 26239052
|
|
7502
Nakata H, Miyazaki T, Iwasaki T, Nakamura A, Kidani T, Sakayama K, Masumoto J, Miura H.
Development of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles.
Oncol. Rep.
2015
33:1593-8
PubMed ID: 25633802
|
|
7528
Fujiwara Y, Shiraishi D, Yoshitomi M, Ikeda T, Mizuta H, Takeya M, Komohara Y
Soyasapogenols contained in soybeans suppress tumour progression by regulating macrophage differentiation into the protumoural phenotype.
J Functional Foods
2015
19:594-605
|
|
15438
Igarashi K, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Odani A, Tsuchiya H.
Effectiveness of two novel anionic and cationic platinum complexes in the treatment of osteosarcoma
Anticancer Agents Med Chem
2015
15(3):390-9
PubMed ID: 25511510
|
|
7854
Zhang D, Pan X, Ohno S, Osuga T, Sawada S, Sato K.
No effects of pulsed electromagnetic fields on expression of cell adhesion molecules (integrin, CD44) and matrix metalloproteinase-2/9 in osteosarcoma cell lines.
Bioelectromagnetics
2011
32:463-73
PubMed ID: 21480303
|
|
7959
Tsubaki M, Yamazoe Y, Yanae M, Satou T, Itoh T, Kaneko J, Kidera Y, Moriyama K, Nishida S.
Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.
Cytokine
2011
54:100-7
PubMed ID: 21292498
|
|
8036
Nakazawa Y, Arai H, Fujita N.
The novel metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in the vasculature by suppressing Zac1/p53-dependent apoptosis.
Cancer Res.
2011
71:1146-55
PubMed ID: 21148752
|
|
5862
Rojas A, González I, Rodríguez B, Romero J, Figueroa H, Llanos J, Morales E, Pérez-Castro R.
Evidence of involvement of the receptor for advanced glycation end-products (RAGE) in the adhesion of Helicobacter pylori to gastric epithelial cells.
Microbes Infect
2011
Sep;13(10):818-23
PubMed ID: 21609778
|
|
8334
Kawano M, Nishida H, Nakamoto Y, Tsumura H, Tsuchiya H.
Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma.
Clin. Orthop. Relat. Res.
2010
468:1373-83
PubMed ID: 20232181
|
|
8693
Kamei S, Sakayama K, Tamashiro S, Aizawa J, Miyawaki J, Miyazaki T, Yamamoto H, Norimatsu Y, Masuno H.
Ketoprofen in topical formulation decreases the matrix metalloproteinase-2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma.
J. Orthop. Res.
2008
27:909-15
PubMed ID: 19105229
|
|
3384
Ando, Takashi, Ichikawa, Jiro, Okamoto, Atsushi, Tasaka, Kachio, Nakao, Atsuhito, Hamada, Yoshiki
Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines.
J Orthop Res
2005
23:964-9
PubMed ID: 16023013
|
Back
Top
CELL BANK Website